[1] MATSUBARA K,MATSUBARA Y,UCHIKURA Y,et al.Pathophysiology of preeclampsia:the role of exosomes[J].Int J Mol Sci,2021,22(5):2572. [2] ROBERTS J M,RICH-EDWARDS J W,MCELRATH T F,et al. Subtypes of preeclampsia:recognition and determining clinical usefulness[J].Hypertension,2021,77(5):1430-1441. [3] 赵静. MicroRNA-195在宫颈癌及子宫上皮瘤变患者外周血中的表达及临床意义[J].江苏大学学报(医学版),2017,27(6):496-499. [4] WU H,WANG H,LIU M,et al. MiR-195 participates in the placental disorder of preeclampsia via targeting activin receptor type-2B in trophoblastic cells[J].J Hypentens,2016,34(7):1371-1379. [5] CHOI S Y,YUN J,LEE O J,et al.MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray[J].Placenta,2013,34(9):799-804. [6] 谢幸,孔北华,段涛. 妇产科学(第九版)[M]. 北京:人民卫生出版社,2018:353-355. [7] OPICHKA M A.Vascular dysfunction in preeclampsia[J].Cells,2021,10(11):3055. [8] 殷莹,戴雅文,陈艳. 探讨妊娠期糖尿病并发子痫前期的危险因素及其妊娠结局[J].中国医刊,2021,56(10):1107-1109. [9] GATHIRAM P.Pre-eclampsia:its pathogenesis and pathophysiolgy[J].Cardiovasc J Afr,2016,27(2):71-78. [10] 尹学敬.子痫前期患者血清中miR-423-5p和miR-204-5p的表达及临床意义[J].实用医学杂志,2019,35(21):3312-3315. [11] 王莉,陈小菊,郑林媚. miR-204在子痫前期患者胎盘组织中的表达及对滋养细胞增殖和侵袭功能影响观察[J].山东医药,2018,58(35):14-18.
2022, Vol. 39 
